Dijia Pharmaceutical Group

Dijia Pharmaceutical Group is a comprehensive pharmaceutical enterprise based in Weihai, China, and serves as the primary pharmaceutical arm of the Weigao Group. The company specializes in the research, development, and large-scale production of Active Pharmaceutical Ingredients (APIs) and finished dosage forms, particularly in the fields of cardiovascular, anti-infective, and endocrine medicine. Dijia operates several high-standard manufacturing facilities that are GMP-certified, enabling them to supply high-quality chemical drugs to both domestic and international markets. In addition to its own product portfolio, the group provides CDMO services, leveraging its integrated supply chain from chemical intermediates to final drug products. Their commitment to innovation is supported by a dedicated R&D center focused on developing complex generics and improving manufacturing efficiencies.